{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:44:40Z","timestamp":1793357080410,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2928,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/sj.ki.5002553","type":"journal-article","created":{"date-parts":[[2007,9,26]],"date-time":"2007-09-26T14:51:33Z","timestamp":1190818293000},"page":"1429-1447","source":"Crossref","is-referenced-by-count":153,"title":["Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : Workshop recommendations"],"prefix":"10.1016","volume":"72","author":[{"given":"D.C.","family":"Cattran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Heering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.F.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Meyrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ponticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Praga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1038\/sj.ki.5002553_bb0010","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/ndt\/14.suppl_3.68","article-title":"Clinical picture and outcome of primary focal segmental glomerulosclerosis","volume":"14","author":"Korbet","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1152\/physiolgenomics.00201.2004","article-title":"Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population","volume":"21","author":"Orloff","year":"2005","journal-title":"Physiol Genomics"},{"key":"10.1038\/sj.ki.5002553_bb0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis \u2014a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002553_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncpneph0025","article-title":"Mechanisms of disease: focal segmental glomerulosclerosis","volume":"1","author":"Meyrier","year":"2005","journal-title":"Nat Clin Practice Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0030","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","article-title":"Proteinuria and the risk of developing end-stage renal disease","volume":"63","author":"Iseki","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","article-title":"Chronic kidney disease: the global challenge","volume":"365","author":"El Nahas","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002553_bb0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1523-1755.2005.67097.x","article-title":"Pathways to nephron loss starting from glomerular diseases\u2014insights from animal models","volume":"67","author":"Kriz","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0045","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1523-1755.1998.00874.x","article-title":"Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. \u2018Gruppo Italiano di Studi Epidemiologici in Nefrologia\u2019 (GISEN)","volume":"53","author":"Ruggenenti","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.SLA.0000055547.93484.87","article-title":"Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials","volume":"237","author":"Vincent","year":"2003","journal-title":"Ann Surg"},{"key":"10.1038\/sj.ki.5002553_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000187205","article-title":"Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted?","volume":"63","author":"Bellomo","year":"1993","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5002553_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1651-2227.1986.tb10294.x","article-title":"Thromboembolic complications in children with nephrotic syndrome. Risk and incidence","volume":"75","author":"Hoyer","year":"1986","journal-title":"Acta Paediatr Scand"},{"key":"10.1038\/sj.ki.5002553_bb0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart disease associated with nephrotic syndrome","volume":"44","author":"Ordonez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002553_bb0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-2008-1033800","article-title":"The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft f\u00fcr P\u00e4d iatrische nephrologie (APN)","volume":"194","author":"Brodehl","year":"1982","journal-title":"Klin Padiatr"},{"key":"10.1038\/sj.ki.5002553_bb0080","first-page":"380","article-title":"Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children","volume":"1","author":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","year":"1988","journal-title":"Lancet"},{"issue":"Suppl 70","key":"10.1038\/sj.ki.5002553_bb0085","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1523-1755.1999.07002.x","article-title":"Management of minimal lesion glomerulonephritis\u2014\u2013 evidence-based recommendations","volume":"55","author":"Bargman","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0090","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2001.0590051983.x","article-title":"Idiopathic membranous glomerulonephritis","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0095","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1523-1755.2004.00873.x","article-title":"Toronto Glomerulonephritis Registry Group: Idiopathic membranous nephropathy: definition and relevance of a partial remission","volume":"66","author":"Troyanov","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Focal and segmental glomerulosclerosis: definition and relevance of a partial remission","volume":"16","author":"Troyanov","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0105","series-title":"Cyclosporin in The Therapy Of Renal Disease. Contrib Nephrol","first-page":"1","article-title":"Current concepts of pathogenesis of nephrotic syndrome","volume":"Vol 7","author":"Tejani","year":"1995"},{"key":"10.1038\/sj.ki.5002553_bb0110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/cs0820641","article-title":"Effects of cyclosporin on glomerular barrier function in nephrotic syndrome","volume":"82","author":"Zietse","year":"1992","journal-title":"Clin Sci"},{"key":"10.1038\/sj.ki.5002553_bb0115","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ki.1994.189","article-title":"Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome","volume":"45","author":"Meyrier","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0120","first-page":"290","article-title":"Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy","volume":"7","author":"Ambalavanan","year":"1996","journal-title":"J Am Soc"},{"key":"10.1038\/sj.ki.5002553_bb0125","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1055\/s-2001-17603","article-title":"Influence of cyclosporine A on renal function in patients with glomerulonephritis. Deutsche Med","volume":"126","author":"Heering","year":"2001","journal-title":"Wochenschrift"},{"key":"10.1038\/sj.ki.5002553_bb0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/path.1711660313","article-title":"Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis","volume":"166","author":"Kokui","year":"1992","journal-title":"J Pathol"},{"key":"10.1038\/sj.ki.5002553_bb0135","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/ndt\/10.7.1149","article-title":"Cyclosporin A reduces albuminuria in experimental anti-GBM nephritis indendently from changes in GFR","volume":"10","author":"Schrijver","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0140","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000189558","article-title":"Antiproteinuric effect of cyclosporin A in adriamycin nephropathy in rats","volume":"75","author":"Desassis","year":"1997","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5002553_bb0145","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.ASN.0000046964.15831.16","article-title":"Cyclosporine A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): results from a canine model","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0150","first-page":"1287","article-title":"Transplantation: toxicokinetics and mechanisms of toxicity of cyclosporine and macrolides","volume":"4","author":"Serkova","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1038\/sj.ki.5002553_bb0155","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/01.TP.0000085046.39523.D5","article-title":"C2 monitoring in maintenance renal transplant recipients: is it worthwhile?","volume":"76","author":"Midtvedt","year":"2003","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5002553_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1592\/phco.25.1.52.55617","article-title":"More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome","volume":"25","author":"Kusaba","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"Suppl 26","key":"10.1038\/sj.ki.5002553_bb0165","first-page":"1","article-title":"A consensus report: cyclosporin A therapy for psoriasis","volume":"122","author":"Mihatsch","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1038\/sj.ki.5002553_bb0170","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1056\/NEJM199206183262502","article-title":"Risk factors for cyclosporin-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of cyclosporin in autoimmune diseases","volume":"326","author":"Feutren","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5002553_bb0175","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0190-9622(97)70205-6","article-title":"Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure","volume":"37","author":"Lowe","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.ki.5002553_bb0180","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/adc.2005.080960","article-title":"Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome","volume":"91","author":"Fujinaga","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1038\/sj.ki.5002553_bb0185","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.tp.0000256179.14038.e2","article-title":"Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression","volume":"83","author":"Kandaswamy","year":"2007","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5002553_bb0190","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.transproceed.2006.02.070","article-title":"Urinary transforming growth factor-beta-induced gene-h3 (betaig-h3) as a sensitive predictor in chronic cyclosporine nephrotoxicity","volume":"38","author":"Kim","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1038\/sj.ki.5002553_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/CBM-2005-1107","article-title":"Protein biomarkers of nephrotoxicity; a review and findings with cyclosporin A, a signal transduction kinase inhibitor and N-phenylanthranilic acid","volume":"1","author":"Betton","year":"2005","journal-title":"Cancer Biomark"},{"key":"10.1038\/sj.ki.5002553_bb0200","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00467-004-1508-y","article-title":"Single-dose daily administration of cyclosporine A for relapsing nephrotic syndrome","volume":"19","author":"Tanaka","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0205","first-page":"779A","article-title":"Advantage of preprandial cyclosporine (CyA) administration for absorption profile in nephrotic syndrome","volume":"16","author":"Ogahara","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0002-9343(81)90754-3","article-title":"Renal failure in minimal change nephrotic syndrome","volume":"70","author":"Lowenstein","year":"1981","journal-title":"Am J Med"},{"key":"10.1038\/sj.ki.5002553_bb0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ndt\/16.2.221","article-title":"Pathophysiology of acute renal failure in idiopathic nephrotic syndrome","volume":"16","author":"Koomans","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01956754","article-title":"Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie","volume":"152","author":"Ehrich","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1038\/sj.ki.5002553_bb0225","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset nephrotic syndrome: a long-term follow-up","volume":"29","author":"Nolasco","year":"1986","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000167603","article-title":"Minimal-change glomerulopathy of adulthood","volume":"8","author":"Korbet","year":"1988","journal-title":"Am J Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0235","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/adc.66.6.751","article-title":"Eight and 12 week courses of cyclophosphamide in nephrotic syndrome","volume":"66","author":"Oemar","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1038\/sj.ki.5002553_bb0240","series-title":"Oxford Textbook of Clinical Nephrology","first-page":"439","article-title":"Minimal change and focal-segmental glomerulosclerosis","volume":"vol 1.","author":"Meyrier","year":"2005"},{"key":"10.1038\/sj.ki.5002553_bb0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","article-title":"A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome","volume":"58","author":"Yoshioka","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0250","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0140-6736(91)93257-A","article-title":"Levimasole for corticosteroid-dependent nephrotic syndrome in childhood","volume":"337","author":"British Association for Paediatric Nephrology","year":"1991","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002553_bb0255","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.00550206","article-title":"Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study group","volume":"1","author":"Hogg","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0260","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1523-1755.2002.00214.x","article-title":"Mycophenolate mofetil treatment for primary glomerular disease","volume":"61","author":"Choi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0265","first-page":"289","article-title":"Report of the Canadian hypertension society consenus conference. I. introduction","volume":"149","author":"Carruthers","year":"1993","journal-title":"Can Med Assoc J"},{"key":"10.1038\/sj.ki.5002553_bb0270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(86)90017-6","article-title":"Cyclosporin in frequently relapsing minimal change nephrotic syndrome","volume":"2","author":"Hoyer","year":"1986","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5002553_bb0275","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2005090922","article-title":"Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective randomized trial","volume":"17","author":"Hoyer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0280","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000186526","article-title":"A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children","volume":"59","author":"Tejani","year":"1991","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5002553_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00856817","article-title":"Comparison of cyclosporine and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial","volume":"6","author":"Niaudet","year":"1992","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0290","first-page":"1326","article-title":"Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial","volume":"8","author":"Ponticelli","year":"1993","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5002553_bb0295","first-page":"S37","article-title":"Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology","volume":"35","author":"Meyrier","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0300","first-page":"14","article-title":"Treatment of idiopathic nephrotic syndrome with cyclosporine A","volume":"10","author":"Meyrier","year":"1997","journal-title":"J Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0305","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/ndt\/gfi059","article-title":"Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience","volume":"20","author":"El-Husseini","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0310","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00856511","article-title":"Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood","volume":"8","author":"Hulton","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0315","first-page":"143","article-title":"Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults","volume":"55","author":"Matsumoto","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0320","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s004670050557","article-title":"One centre experience with cyclosporine in refractory nephrotic syndrome in children","volume":"13","author":"Singh","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00063030-199912050-00002","article-title":"The place of cyclosporine in the management of primary nephrotic syndrome","volume":"12","author":"Ponticelli","year":"1999","journal-title":"Biodrugs"},{"key":"10.1038\/sj.ki.5002553_bb0330","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2002.00303.x","article-title":"Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome","volume":"61","author":"Iijima","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0335","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.V541049","article-title":"Cyclosporine in the treatment of idiopathic nephrosis","volume":"4","author":"Niaudet","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0340","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000424287","article-title":"Serial renal biopsies in children with idiopathic nephrosis receiving cyclosporine","volume":"114","author":"Niaudet","year":"1995","journal-title":"Contrib Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0345","series-title":"Cochrane Systematic","article-title":"Non-corticosteroid treatment for nephrotic syndrome in children","author":"Durkan","year":"2006"},{"key":"10.1038\/sj.ki.5002553_bb0350","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar Oz","year":"2001","journal-title":"Transplantation"},{"key":"10.1038\/sj.ki.5002553_bb0355","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1523-1755.2004.00775.x","article-title":"Prevalence of WT1 mutation in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome","volume":"66","author":"Ruf","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0360","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/74166","article-title":"NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome","volume":"24","author":"Boute","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/sj.ki.5002553_bb0365","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1126\/science.1081068","article-title":"CD-2 associated protein haploinsufficiency is linked to glomerular disease susceptibility","volume":"300","author":"Kim","year":"2003","journal-title":"Science"},{"key":"10.1038\/sj.ki.5002553_bb0370","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/73456","article-title":"Mutations in ACTN4, encoding a-actinin-4, cause familial focal segmental glomerulosclerosis","volume":"24","author":"Kaplan","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/sj.ki.5002553_bb0375","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1106215","article-title":"A mutation in the TRCP6 cation channel causes familial focal segmental glomerulosclerosis","volume":"308","author":"Winn","year":"2005","journal-title":"Science"},{"key":"10.1038\/sj.ki.5002553_bb0380","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/ndt\/gfh961","article-title":"Slit or pore? A mutation of the ion channel TRPC6 causes FSGS","volume":"20","author":"Walz","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0385","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","article-title":"Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome","volume":"15","author":"Ruf","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0390","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/snep.2003.50020","article-title":"Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis","volume":"23","author":"Korbet","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0395","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1046\/j.1523-1755.2002.00674.x","article-title":"Treatment of primary focal segmental glomerulosclerosis","volume":"62","author":"Korbet","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0400","first-page":"309","article-title":"Treatment of focal segmental glomerulosclerosis","volume":"20","author":"Matalon","year":"2000","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0405","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0272-6386(99)70384-7","article-title":"Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?","volume":"34","author":"Ponticelli","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002553_bb0410","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00467-003-1207-0","article-title":"Interventions for steroid-resistant nephrotic syndrome: a systematic review","volume":"18","author":"Habashy","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0415","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","article-title":"A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis","volume":"56","author":"Cattran","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0420","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0425","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.ajkd.2003.09.027","article-title":"Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis","volume":"43","author":"Heering","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002553_bb0430","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/ndt\/15.9.1348","article-title":"Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis","volume":"15","author":"Alexopoulos","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0435","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1681\/ASN.V7156","article-title":"A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children","volume":"7","author":"Lieberman","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0440","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1681\/ASN.V32254","article-title":"Severe hypercholesterolemia inhibits cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome","volume":"3","author":"Ingulli","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0445","first-page":"c97","article-title":"Second hour measurement of cyclosporine (C2) in children with nephrotic syndrome","volume":"17","author":"Mitsoni","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0450","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0272-6386(99)70138-1","article-title":"Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy","volume":"33","author":"Laluck","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002553_bb0455","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0272-6386(95)90568-5","article-title":"A review of therapeutic studies of idiopathic membranous glomerulopathy","volume":"25","author":"Hogan","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5002553_bb0460","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1523-1755.2004.00518.x","article-title":"Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan","volume":"65","author":"Shiiki","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0465","first-page":"85","article-title":"Remissions and relapses in idiopathic membranous nephropathy","volume":"7","author":"Ponticelli","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0470","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy","volume":"48","author":"Ponticelli","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0475","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy","volume":"9","author":"Ponticelli","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0480","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.ajkd.2007.05.015","article-title":"Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide","volume":"50","author":"Wetzels","year":"2007","journal-title":"A J Kidney Dis"},{"key":"10.1038\/sj.ki.5002553_bb0485","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","article-title":"Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0490","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1093\/ndt\/gfl360","article-title":"Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome","volume":"21","author":"Alexopoulos","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0495","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.1995.161","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy","volume":"47","author":"Cattran","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5002553_bb0500","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000187219","article-title":"Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy","volume":"63","author":"Rostoker","year":"1993","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5002553_bb0505","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ndt\/14.4.1036","article-title":"Treatment of membranous glomerulonephropathy with cyclosporin A: how much patience is required?","volume":"14","author":"Fritsche","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5002553_bb0510","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s101570050068","article-title":"Effect of cyclosporine therapy on idiopathic membranous nephropathy presented with refractory nephrotic syndrome","volume":"4","author":"Iida","year":"2000","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0515","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00467-006-0246-8","article-title":"Idiopathic membranous nephropathy in children","volume":"21","author":"Lee","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/sj.ki.5002553_bb0520","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1440-1797.2002.00087.x","article-title":"Efficacy of cyslosporin in difficult-to-treat idiopathic membranous nephropathy","volume":"7","author":"Alexopoulos","year":"2002","journal-title":"Nephrology"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815525908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815525908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T08:37:01Z","timestamp":1629794221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815525908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":103,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0085253815525908"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5002553","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}